Malays. J. Anal. Sci. Volume 30 Number 2 (2026): 1724

 

Research Article

 

Antioxidant potential of vanillin Schiff base hybrids: Insights from in silico molecular docking, ADMET, and in vitro DPPH assay

 

Mohamad Azmeer Hissam, and Zainab Ngaini*

 

Faculty of Resource Science and Technology, Universiti Malaysia Sarawak, Jalan Datuk Mohammad Musa, 94300 Kota Samarahan, Sarawak, Malaysia.

 

*Corresponding author: nzainab@unimas.my

 

Received: 24 September 2025; Revised: 6 January 2026; Accepted: 1 March 2026; Published: 28 April 2026

 

Abstract

Oxidative stress is a primary driver of chronic disease.  However, many synthetic antioxidants are limited by toxicity and instability. While vanillin is a promising natural scaffold, the influence of electron-withdrawing group (EWG) (i.e. halogen or NO2) on its antioxidant efficacy remains an important area of exploration. This study aimed to synthesise and evaluate vanillin Schiff base hybrids (1a-g) for their antioxidant potential. The synthesised compounds were screened for radical-scavenging activity using DPPH assay. Molecular interactions were explored through docking studies against human 5-lipoxygenase (PDB ID: 6N2W) and further complemented by ADMET profiling to assess pharmacokinetic viability and adherence to Lipinski’s Rule of Five. The derivatives exhibited antioxidant activity, with IC50 values ranging from 386.01 to 1,060.05 µM. Compound 1f emerged as the most active (IC50 = 386.01 µM) among the synthesised compounds. Docking analysis revealed favourable binding affinities (-6.30 to -6.00 kcal/mol) while ADMET analysis showed that vanillin Schiff bases possess a consistent profile of oral drug-likeliness. These findings establish the vanillin Schiff base framework as a potential lead scaffold for further structural refinement. This research contributes to ongoing efforts in antioxidant development in support of the United Nation SDG 3: Good Health and Well-Being.

 

Keywords: condensation, electron delocalisation, hydrogen atom transfer, single-electron transfer, SwissADME

 

References

1.        Hissam, M. A., Ngaini, Z., Patrick Mesebasio, S. I. and Jefree Shahren, D. A. (2025). Synthesis, antibacterial, antioxidant, molecular docking and ADMET properties of halogenated vanillin azo-chalcone. Discover Applied Sciences, 7(7): 654.

2.        Blaikie, L., Kay, G. and Kong Thoo Lin, P. (2020). Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters, 30(21): 127505.

3.        Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I. and Lee, S. J. (2025). Free radicals and their impact on health and antioxidant defenses: a review. Cell Death Discovery, 11(1): 19.

4.        Ngaini, Z., Hissam, M. A., Mortadza, N. A., Abd Halim, A. N. and  Daud, A. I. (2023). In vitro antimicrobial activities, molecular docking and density functional theory (DFT) evaluation of natural product-based vanillin derivatives featuring halogenated azo dyes. Natural Product Research, 38(21): 3762–3772.

5.        Tai, A., Sawano, T., Yazama, F. and Ito, H. (2011). Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochimica et Biophysica Acta - General Subjects, 1810(2): 170–177.

6.        Sobola, A. (2018). Synthesis, characterization and antimicrobial activity of p-vanillin and vanillin Schiff bases. Journal of Research and Review in Science, 5(1): 51–57.

7.        Gulsia, O. (2020). Vanillin: One Drug, Many Cures. Resonance, 25(7): 981–986.

8.        Platzer, M., Kiese, S., Tybussek, T., Herfellner, T., Schneider, F., Schweiggert-Weisz, U. and Eisner, P. (2022). Radical scavenging mechanisms of phenolic compounds: A quantitative structure-property relationship (QSPR) study. Frontiers in Nutrition, 9(4): 4–8.

9.        Atshan, D. A. and Zalzala, M. H. (2024). Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats. Current Research in Pharmacology and Drug Discovery, 6: 100177.

10.     Suleiman, M., Sankaranarayanan, M., Theva Das, K., Amran, S. I., Berezin, V., Andrey, B. and Jamalis, J. (2025). Vanillin Derivatives in Drug Design: Structure–activity relationship (SAR) hotspots and synthetic pathways for enhanced pharmacological activity. ACS Omega, 10(48), 57846-57875.

11.     Khan, R., Rashid, S., Khan, S., Almutawif, Y. A. and Pari, B. (2024). Synthesis and evaluation of vanillin Schiff bases as potential antimicrobial agents against ESBL-producing bacteria: towards novel interventions in antimicrobial stewardship. Scientific Reports, 14(1): 28007.

12.     Yıldırım, M., Ünver, H., Necip, A. and Çimentepe, M. (2025). Design, synthesis, and biological evaluation of novel vanillin-derived hydrazone compounds with antimicrobial, anticancer, and enzyme inhibition activities, along with molecular structure and drug-likeness assessment. Biochemical and Biophysical Research Communications, 775: 152173.

13.     Matiadis, D., Tsironis, D., Stefanou, V., Boussias, S., Panagiotopoulou, A., McKee, V., Igglessi-Markopoulou, O. and Markopoulos, J. (2020). Synthesis, biological evaluation and structure-activity relationships of 5-arylidene tetramic acids with antibacterial activity against methicillin-resistant Staphylococcus aureus. Bioorganic and Medicinal Chemistry Letters, 30(10), 127107.

14.     Saeed, A. M., AlNeyadi, S. S. and Abdou, I. M. (2020). Anticancer activity of novel Schiff bases and azo dyes derived from 3-amino-4-hydroxy-2H-pyrano[3,2-c]quinoline-2,5(6H)-dione. Heterocyclic Communications, 26(1): 192–205.

15.     Elkanzi, N. A. A., Hrichi, H. and Bakr, R. B. (2022). Antioxidant, antimicrobial, and molecular docking studies of novel chalcones and schiff bases bearing 1, 4-naphthoquinone moiety. Letters in Drug Design & Discovery, 19(7): 654–673.

16.     Sinicropi, M. S., Ceramella, J., Iacopetta, D., Catalano, A., Mariconda, A., Rosano, C., Saturnino, C., El-Kashef, H. and Longo, P. (2022). Metal complexes with Schiff bases: Data collection and recent studies on biological activities. International Journal of Molecular Sciences, 23(23): 14840.

17.     Hassan, A. U., Sumrra, S. H., Zafar, M. N., Nazar, M. F., Mughal, E. U., Zafar, M. N. and Iqbal, M. (2022). New organosulfur metallic compounds as potent drugs: synthesis, molecular modeling, spectral, antimicrobial, drug likeness and DFT analysis. Molecular Diversity, 26(1): 51–72.

18.     Rana, M. S., Rayhan, N. M. A., Emon, M. S. H., Islam, M. T., Rathry, K., Hasan, M. M., Islam Mansur, M. M., Srijon, B. C., Islam, M. S., Ray, A., Rakib, M. A., Islam, A., Kudrat-E-Zahan, M., Hossen, M. F. and Asraf, M. A. (2024). Antioxidant activity of Schiff base ligands using the DPPH scavenging assay: an updated review. RSC Advances, 14(45): 33094–33123.

19.     Nemeth, T., de Wild, T., Gubler, L. and Nauser, T. (2022). Impact of substitution on reactions and stability of one-electron oxidised phenyl sulfonates in aqueous solution. Physical Chemistry Chemical Physics, 24(2): 895–901.

20.     Çolak, N., Savcı, A., Turan, N. and Buldurun, K. (2025). Preparation, spectral characterization and antioxidant activities of aminothiophene-containing schiff base and co(ii) and pd(ii) complexes. Journal of Biochemical and Molecular Toxicology, 39(3): 1–8.

21.     Zheng, Y.-Z., Deng, G., Guo, R., Chen, D.-F. and Fu, Z.-M. (2019). DFT studies on the antioxidant activity of naringenin and its derivatives: effects of the substituents at C3. International Journal of Molecular Sciences, 20(6): 1450.

22.     Gilbert, N. C., Gerstmeier, J., Schexnaydre, E. E., Börner, F., Garscha, U., Neau, D. B., Werz, O. and Newcomer, M. E. (2020). Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nature Chemical Biology, 16(7): 783–790.

23.     Abd Halim, A. N., Yeo, K. W., Zamakshshari, N. H., Phornvillay, S., Ngaini, Z. and Noissy Diosing, D. (2024). Preparation, in vitro and in silico antioxidant and antibacterial studies of 4-aminoacetanilide azo derivatives. Journal of the Indian Chemical Society, 101(11): 101341.

24.     Hissam, M. A., Ngaini, Z., Zamakshshari, N. H., Hejemi, F. N. A. M., Arni, F. S. and Halim, A. N. A. (2024). Synthesis and molecular docking simulation on the antimicrobial effects of halogenated vanillin-azo dyes and schiff base derivatives. Discover Applied Sciences, 6(6): 325.

25.     Chigurupati, S. (2015). Designing new vanillin schiff bases and their antibacterial studies. Journal of Medical and Bioengineering, 4(5): 363–366.

26.     Trott, O. and Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2): 455–461.

27.     Perkins, A., Nelson, K. J., Parsonage, D., Poole, L. B. and Karplus, P. A. (2015). Peroxiredoxins: Guardians against oxidative stress and modulators of peroxide signaling. Trends in Biochemical Sciences, 40(8): 435–445.

28.     Daina, A., Michielin, O. and Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1): 42717.

29.     Pires, D. E. V., Blundell, T. L. and Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9): 4066–4072.

30.     Chagas, C. M., Moss, S. and Alisaraie, L. (2018). Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. International Journal of Pharmaceutics, 549(2): 133–149.

31.     Ayuba, I., Ibrahim, T. S., Aishatu, U. M. and Buhari, M. (2022). Synthesis, characterization and anti-bacterial activity of Schiff Base and its mixed ligand complexes of Cr (II) and Co (II) containing vanillin and 2-aminophenol. Dutse Journal of Pure and Applied Sciences, 7(4): 98–104.

32.     Dong, X., Oganov, A. R., Cui, H., Zhou, X. F. and Wang, H. T. (2022). Electronegativity and chemical hardness of elements under pressure. Proceedings of the National Academy of Sciences of the United States of America, 119(10): 1–8.

33.     Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C. and Boeckler, F. M. (2013). Principles and applications of halogen bonding in medicinal chemistry and chemical biology. Journal of Medicinal Chemistry, 56(4): 1363–1388.

34.     Nordin, N. A., Lawai, V., Ngaini, Z., Abd Halim, A. N., Hwang, S. S., Linton, R. E., Lee, B. K. and Neilsen, P. M. (2020). In vitro cytotoxicity evaluation of thiourea derivatives bearing Salix sp. constituent against HK-1 cell lines. Natural Product Research, 34(11): 1505–1514.

35.     Bērziņa, L. and Mieriņa, I. (2023). Antiradical and antioxidant activity of compounds containing 1,3-dicarbonyl moiety: An overview. Molecules, 28(17), 6203.

36.     Khoshbakht, A., Shiran, J. A., Miran, M. and Sepehri, S. (2024). Synthesis and evaluation of in vitro antioxidant, anticancer, and antibacterial properties of new benzylideneiminophenyl thiazole analogues. BMC Chemistry, 18(1): 173.

37.     Ley-Martínez, J. S., Ortega-Valencia, J. E., García-Barradas, O., Jiménez-Fernández, M., Uribe-Lam, E., Vencedor-Meraz, C. I. and Oliva-Ramírez, J. (2022). Active compounds in zingiber officinale as possible redox inhibitors of 5-lipoxygenase using an in silico approach. International Journal of Molecular Sciences, 23(11): 6093.

38.     Hissam, M. A., Ngaini, Z., Mortadza, N. A., Daud, A. I. and Farooq, S. (2025). Microwave-assisted synthesis and dual in silico–in vitro profiling of vanillin azo-Schiff base hybrids for antimicrobial potential. Discover Applied Sciences, 7(12): 1407.  

39.     Kahnt, A. S., Angioni, C., Göbel, T., Hofmann, B., Roos, J., Steinbrink, S. D., Rörsch, F., Thomas, D., Geisslinger, G., Zacharowski, K., Grösch, S., Steinhilber, D. and Maier, T. J. (2022). Inhibitors of human 5-lipoxygenase potently interfere with prostaglandin transport. Frontiers in Pharmacology, 12(1): 1–13.

40.     Manda, G., Rojo, A. I., Martínez-Klimova, E., Pedraza-Chaverri, J. and Cuadrado, A. (2020). Nordihydroguaiaretic acid: From herbal medicine to clinical development for cancer and chronic diseases. Frontiers in Pharmacology, 11(2): 1–21.

41.     Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A. and Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS ONE, 5(8).

42.     Mortadza, N. A., & Ngaini, Z. (2023). Microwave-assisted and conventional synthesis of halogenated coumarin-azo derivatives and structural-activity relationship study for antimicrobial potential. Malaysian Journal of Analytical Sciences, 27(2): 342–352.

43.     Ngaini, Z., Jefferi, M. A. and Farooq, S. (2024). Synthesis, molecular docking, ADMET studies and antimicrobial activities of coumarin-chalcone hybrid derivatives. Natural Product Research: 1–10.

44.     Aarjane, M., Aouidate, A., Slassi, S. and Amine, A. (2020). Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone. Arabian Journal of Chemistry, 13(7): 6236–6245.

45.     Niazi, S. K. (2023). Non-invasive drug delivery across the blood–brain barrier: A prospective analysis. Pharmaceutics, 15(11): 2599.

46.     Yang, P., Luo, J.-B., Wang, Z.-Z., Zhang, L.-L., Feng, J., Xie, X.-B., Shi, Q.-S. and Zhang, X.-G. (2021). Synthesis, molecular docking, and evaluation of antibacterial activity of 1,2,4-triazole-norfloxacin hybrids. Bioorganic Chemistry, 115: 105270.

47.     Saxena, P., Zangerl-Plessl, E.-M., Linder, T., Windisch, A., Hohaus, A., Timin, E., Hering, S. and Stary-Weinzinger, A. (2016). New potential binding determinant for hERG channel inhibitors. Scientific Reports, 6(1): 24182.

48.     Hakkola, J., Hukkanen, J., Turpeinen, M. and Pelkonen, O. (2020). Inhibition and induction of CYP enzymes in humans: An update. Archives of Toxicology, 94(11): 3671–3722.

49.     Björnsson, E. (2016). Hepatotoxicity by drugs: The most common implicated agents. International Journal of Molecular Sciences, 17(2): 224.